This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 May;2(1):53.

doi: 10.1016/S1533-0028(11)70503-5.

Can eniluracil improve 5-fluorouracil therapy?

Robert B Diasio¹

Affiliations

PMID: 12453337
DOI: 10.1016/S1533-0028(11)70503-5

Comment

Can eniluracil improve 5-fluorouracil therapy?

Robert B Diasio. Clin Colorectal Cancer. 2002 May.

. 2002 May;2(1):53.

doi: 10.1016/S1533-0028(11)70503-5.

Author

Robert B Diasio¹

Affiliation

¹ Departments of Pharmacology/Toxicology and Medicine, Comprehensive Cancer Center, University of Alabama at Birmingham, USA.

PMID: 12453337
DOI: 10.1016/S1533-0028(11)70503-5

No abstract available

PubMed Disclaimer

Comment on

Eastern Cooperative Oncology Group phase II trial (E4296) of oral 5-fluorouracil and eniluracil as a 28-day regimen in metastatic colorectal cancer.
Marsh JC, Catalano P, Huang J, Graham DL, Cornfeld MJ, O'Dwyer PJ, Benson AB 3rd. Marsh JC, et al. Clin Colorectal Cancer. 2002 May;2(1):43-50. doi: 10.3816/CCC.2002.n.010. Clin Colorectal Cancer. 2002. PMID: 12453335 Clinical Trial.

Similar articles

Inhibiting 5-fluorouracil breakdown: a broken down approach to 5-fluorouracil modulation.
Schilsky RL. Schilsky RL. Clin Colorectal Cancer. 2002 May;2(1):51-2. doi: 10.1016/S1533-0028(11)70502-3. Clin Colorectal Cancer. 2002. PMID: 12453336 No abstract available.
Clinical development of eniluracil: current status.
Hohneker JA. Hohneker JA. Oncology (Williston Park). 1998 Oct;12(10 Suppl 7):52-6. Oncology (Williston Park). 1998. PMID: 9830627 Review.
[5-fluorouracil and dihydropyrimidine dehydrogenase].
Kubota T. Kubota T. Gan To Kagaku Ryoho. 2001 Apr;28(4):433-9. Gan To Kagaku Ryoho. 2001. PMID: 11329775 Review. Japanese.
UFT and eniluracil, oral variations of 5-FU, offer lower toxicity, phase II results show.
[No authors listed] [No authors listed] Oncologist. 1999;4(1):84. Oncologist. 1999. PMID: 10337376 No abstract available.
Eniluracil: an irreversible inhibitor of dihydropyrimidine dehydrogenase.
Schilsky RL, Kindler HL. Schilsky RL, et al. Expert Opin Investig Drugs. 2000 Jul;9(7):1635-49. doi: 10.1517/13543784.9.7.1635. Expert Opin Investig Drugs. 2000. PMID: 11060767 Review.

See all similar articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.